Clinical trial

Targeted Retreatment of COPD Exacerbations

NCT02300220

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-05-05

PhasePHASE3

Study timeline

Study start (actual)2014-05-05Date precision: day

Registry last updated2021-03-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Disease (COPD)unresolved

Interventions

CiprofloxacinDRUG · verified · RxNorm: ciprofloxacin

PlaceboDRUG

Sponsors & collaborators

Imperial College Londonlead sponsor

Mapped research locations

LondonUnited Kingdom3 LiverpoolUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02300220 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.